[ad_1] Text size Teladoc cut its financial outlook for the year. Courtesy of Teladoc Teladoc Health shares tumbled 38% in…
[ad_1] U.S. stocks fell sharply Friday, as investors continued to weigh hawkish comments on interest rates by Federal Reserve Chairman…
[ad_1] Stock markets look set to kick off with small losses Monday, resuming the weakness seen in last week’s holiday…
[ad_1] Text size First-quarter earnings season picks up next week, with 67 S&P 500 companies scheduled to report. Bank of…
[ad_1] Text size Nasdaq-listed Antares Pharma is being bought by Halozyme Therapeutics in a deal valued at $960 million. Michael…